Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 181 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients

 		Familial Mediterranean Fever, Still Disease, Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still Disease Switzerland NCT07517250

A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany

 		Leukemia, Chronic Myeloid Germany NCT07549516

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

 		Advanced Malignancies and Hepatic Impairment Phase1 France
Italy
Spain
United Kingdom
View all
 NCT07422610

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

 		Metastatic Castration-resistant Prostate Cancer (mCRPC) Phase1 Australia
Canada
Germany
Italy
Japan
South Korea
Spain
United States
View all
 NCT07570979

Remibrutinib Open Label Roll-over Post-trial Access Protocol

 		Indication of the Parent Protocol Phase3 Bulgaria
Canada
Colombia
Czechia
France
Poland
South Korea
Spain
Vietnam
View all
 NCT07456891

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

 		Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) Phase3 Australia
Belgium
China
France
Germany
Italy
Japan
Netherlands
South Korea
Spain
United Kingdom
United States
View all
 NCT07498426

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

 		Primary Immune Thrombocytopenia (ITP), Primary Evans Syndrome (ES) Phase2 United States NCT07421167

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

 		Heterozygous or Homozygous Familial Hypercholesterolemia Phase3 Taiwan
United States 		NCT05682378

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

 		Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive Phase2 Australia
Brazil
Canada
China
France
Germany
Hungary
Italy
Japan
Netherlands
Poland
South Korea
Spain
Thailand
United States
View all
 NCT07354074

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population

 		Hidradenitis Suppurativa Italy NCT07543419